ProBioGen inks next Commercial GlymaxX® License with Roche
ADCC-enhancement for innovative cancer therapy
ADCC-enhancement for innovative cancer therapy
Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin are coordinating an international project on the single-cell analysis of the human pancreas. The project is part of a global undertaking – known as the…
Ahead of the European Council negotiations on the next Multiannual Financial Framework,academic and industry leaders supporting the LifeTime initiative, have called members of the European Union into action. They ask to preserve the existing Horizon…
European Advanced infraStructure for Innovative Genomics
Accelerating new rare disease therapies through collaboration agreement
MedTech Innovator is the medical technology industry’s global showcase and accelerator for innovative medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating…
Preclinical study shows long-term suppression of seizures
Nerve cells communicate with one another via signaling molecules. The rule is: the more of these molecules, the stronger the signal. Drugs and diseases influence these processes and can weaken or strengthen the signal. Together with colleagues of…
Asahi Kasei Pharma will launch a grant for joint research or research development mainly on drug discovery seeds and technologies.
The call addresses representatives from research organizations and those from SMEs and start-ups who develop application-oriented technologies and/or processes. 10 tandems - consisting of one representative from the research sector and one from a SME…